The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Boom Is Getting Out of Hand The Atlantic Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury The Peptide Gamble: A Doctor's Warning on BPC 157 and TB 500 FDA's Overreach on Compounded Peptides Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.